Jane Currie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jane Currie has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Anna Louise David
University College London
2 shared publications AL David
EGA Institute for Women's Health UCL London UK
1 shared publication- Catherine P. James
University College London, London, UK
1 shared publication - Hajra Khattak
Tommy’s National Centre for Miscarriage Research, Institute of Metabolism and Systems Research, University of Birmingham , Birmingham, UK
1 shared publication Imogen Montague
University Hospitals Plymouth NHS Trust, Plymouth, UK
1 shared publication- James Malone-Lee
Department of Renal Medicine, Division of Medicine, University College London, London, UK
1 shared publication
Latest Publications
- Open Access
- 5 April 2026
- Published by JMIR Publications Inc. in JMIR Preprints
TU(L)IPS Study: Treatment of asymptomatic Urinary tract (Lower) Infection in Pregnancy Screening - Variation in Asymptomatic Bacteriuria Screening in Pregnancy in the UK — Protocol for a National Multicentre Survey and Retrospective Service Evaluation (Preprint)
BACKGROUND Asymptomatic bacteriuria (ASB) has been associated with preterm birth and pyelonephritis, and until recently, screening for ASB was recommended for all women in first trimester of pregnancy. Recent divergence between NICE guidelines (which do not recommend routine screening) and NHS initiatives such as the Saving Babies’ Lives Care Bundle (which recommends screening in high-risk women) may have led to inconsistencies in UK clinical practice. OBJECTIVE To describe the protocol for a national multicentre study evaluating variation in ASB screening practices across UK maternity units and examining associated maternal and neonatal outcomes. METHODS The TU(L)IPS study is a national, multicentre observational study conducted through the UK Audit and Research Collaborative in Obstetrics and Gynaecology (UKARCOG) network. The study comprises two components: (1) a structured survey of UK maternity units to characterise local ASB screening guidelines and practices, and (2) a retrospective cohort study using routinely collected clinical data to assess adherence to local and national guidance and to describe maternal and neonatal outcomes. Participating sites contribute data via a standardised REDCap-based data collection platform using predefined variables and harmonised outcome definitions. Analyses will be descriptive, including frequencies and proportions, with comparisons stratified by screening status, urine culture result categories, and preterm birth risk groups. RESULTS The study was launched nationally in January 2025. Recruitment closed with 28 NHS Trusts participating across the United Kingdom. Stage 1 data collection was completed in December 2025. Stage 2 data collection is scheduled to conclude in March 2026, with the database lock planned for March 2026. Data cleaning and analysis will commence following the database lock. The anticipated study completion date is May 2026. CONCLUSIONS This study will provide a comprehensive national evaluation of variation in ASB screening practices and associated outcomes in pregnancy. By using a standardised, protocolised approach across multiple sites, the TU(L)IPS study aims to generate contemporary evidence to inform clinical practice and national policy.
- 5 April 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessTU(L)IPS Study: Treatment of asymptomatic Urinary tract (Lower) Infection in Pregnancy Screening - Variation in Asymptomatic Bacteriuria Screening in Pregnancy in the UK — Protocol for a National Multicentre Survey and Retrospective Service Evaluation (Preprint)
BACKGROUND Asymptomatic bacteriuria (ASB) has been associated with preterm birth and pyelonephritis, and until recently, screening for ASB was recommended for all women in first trimester of pregnancy. Recent divergence between NICE guidelines (which do not recommend routine screening) and NHS initiatives such as the Saving Babies’ Lives Care Bundle (which recommends screening in high-risk women) may have led to inconsistencies in UK clinical practice. OBJECTIVE To describe the protocol for a national multicentre study evaluating variation in ASB screening practices across UK maternity units and examining associated maternal and neonatal outcomes. METHODS The TU(L)IPS study is a national, multicentre observational study conducted through the UK Audit and Research Collaborative in Obstetrics and Gynaecology (UKARCOG) network. The study comprises two components: (1) a structured survey of UK maternity units to characterise local ASB screening guidelines and practices, and (2) a retrospective cohort study using routinely collected clinical data to assess adherence to local and national guidance and to describe maternal and neonatal outcomes. Participating sites contribute data via a standardised REDCap-based data collection platform using predefined variables and harmonised outcome definitions. Analyses will be descriptive, including frequencies and proportions, with comparisons stratified by screening status, urine culture result categories, and preterm birth risk groups. RESULTS The study was launched nationally in January 2025. Recruitment closed with 28 NHS Trusts participating across the United Kingdom. Stage 1 data collection was completed in December 2025. Stage 2 data collection is scheduled to conclude in March 2026, with the database lock planned for March 2026. Data cleaning and analysis will commence following the database lock. The anticipated study completion date is May 2026. CONCLUSIONS This study will provide a comprehensive national evaluation of variation in ASB screening practices and associated outcomes in pregnancy. By using a standardised, protocolised approach across multiple sites, the TU(L)IPS study aims to generate contemporary evidence to inform clinical practice and national policy.
- Open Access
- 19 May 2025
- Published by Wiley
Outcomes following first trimester screening for asymptomatic bacteriuria in pregnancy: a retrospective cohort study
Objective What are pregnancy outcomes following screening for asymptomatic bacteriuria, comparing significant growth, mixed growth and non-significant growth against no growth? Design Retrospective cohort study of pregnant women booking for birth. Setting Tertiary UK hospital Population or Sample All patients screened for bacteriuria before twenty weeks’ gestation for whom pregnancy outcome data was available. Methods We used routinely collected data obtained using an automated extract from the hospital electronic patient records database (EPIC, EPIC Systems Corporation) incorporating all patient data including obstetric, neonatal, microbiology and pathology results. Main Outcome Measures Primary outcomes were preterm birth before 37 weeks and pyelonephritis, with pre-planned secondary outcomes including antimicrobial resistance and subgroup analyses. Results 6095 pregnant women met inclusion criteria (6095/10678, 57.1% of all women booked for care in that period). Preterm birth (5 colony forming units per ml (CFU/ml), 203/2942, 6.9%, p5 CFU/ml, 41/604, 6.8%, pConclusions Bacteriuria of any kind was associated with subsequent preterm birth in this large single centre cohort study of booking mid-stream urine culture. Pyelonephritis, although rare, was more common with significant growth, with no cases occurring following no growth.
- 19 May 2025
- Published by Wiley
Open AccessOutcomes following first trimester screening for asymptomatic bacteriuria in pregnancy: a retrospective cohort study
Objective What are pregnancy outcomes following screening for asymptomatic bacteriuria, comparing significant growth, mixed growth and non-significant growth against no growth? Design Retrospective cohort study of pregnant women booking for birth. Setting Tertiary UK hospital Population or Sample All patients screened for bacteriuria before twenty weeks’ gestation for whom pregnancy outcome data was available. Methods We used routinely collected data obtained using an automated extract from the hospital electronic patient records database (EPIC, EPIC Systems Corporation) incorporating all patient data including obstetric, neonatal, microbiology and pathology results. Main Outcome Measures Primary outcomes were preterm birth before 37 weeks and pyelonephritis, with pre-planned secondary outcomes including antimicrobial resistance and subgroup analyses. Results 6095 pregnant women met inclusion criteria (6095/10678, 57.1% of all women booked for care in that period). Preterm birth (5 colony forming units per ml (CFU/ml), 203/2942, 6.9%, p5 CFU/ml, 41/604, 6.8%, pConclusions Bacteriuria of any kind was associated with subsequent preterm birth in this large single centre cohort study of booking mid-stream urine culture. Pyelonephritis, although rare, was more common with significant growth, with no cases occurring following no growth.
- 22 December 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (12) , e261698
Antenatal diagnosis of lethal Costello syndrome: how fetal exome sequencing using NHS England’s R21 pathway accelerated the diagnosis of non-immune hydrops and improved patient experience
Costello syndrome is a very rare genetic condition with a poor prognosis, caused by a mutation in the HRAS gene. We report two lethal cases diagnosed antenatally using recently introduced exome sequencing technology (R21). Without this testing, they are unlikely to have been diagnosed so promptly, which the families found very helpful in coping with their loss.
- 22 December 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (12) , e261698
Antenatal diagnosis of lethal Costello syndrome: how fetal exome sequencing using NHS England’s R21 pathway accelerated the diagnosis of non-immune hydrops and improved patient experience
Costello syndrome is a very rare genetic condition with a poor prognosis, caused by a mutation in the HRAS gene. We report two lethal cases diagnosed antenatally using recently introduced exome sequencing technology (R21). Without this testing, they are unlikely to have been diagnosed so promptly, which the families found very helpful in coping with their loss.
- 17 November 2022
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 42 (8) , 3545-3551
Impact of covid-19 on subspecialty training in obstetrics and gynaecology
The Covid-19 pandemic brought substantial changes in clinical practice in Obstetrics and Gynaecology (O and G). Redeployment of staff and restrictions in elective services raised training concerns. We sought to assess the impact on subspecialty training, to identify issues to help mitigate the impact. We conducted cross-sectional anonymous electronic surveys of UK subspecialty trainees at three time points: June 2020, February 2021, September 2021. Surveys were analysed by descriptive statistics and thematic analysis of free-text responses. Response rates ranged from 30% to 40%, with higher response rates from urogynaecology trainees. Up to 72% reported an impact on training, most notable in gynaecological subspecialties, and particularly urogynaecology, which persisted over time. More than a third anticipated needing extra time to complete training. This raises serious future workforce and patient care concerns. Clinical recovery should consider training needs as essential when re-establishing services. Subspecialty trainees may need additional time to achieve competencies required of future consultants.
- 17 November 2022
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 42 (8) , 3545-3551
Impact of covid-19 on subspecialty training in obstetrics and gynaecology
The Covid-19 pandemic brought substantial changes in clinical practice in Obstetrics and Gynaecology (O and G). Redeployment of staff and restrictions in elective services raised training concerns. We sought to assess the impact on subspecialty training, to identify issues to help mitigate the impact. We conducted cross-sectional anonymous electronic surveys of UK subspecialty trainees at three time points: June 2020, February 2021, September 2021. Surveys were analysed by descriptive statistics and thematic analysis of free-text responses. Response rates ranged from 30% to 40%, with higher response rates from urogynaecology trainees. Up to 72% reported an impact on training, most notable in gynaecological subspecialties, and particularly urogynaecology, which persisted over time. More than a third anticipated needing extra time to complete training. This raises serious future workforce and patient care concerns. Clinical recovery should consider training needs as essential when re-establishing services. Subspecialty trainees may need additional time to achieve competencies required of future consultants.
- Open Access
- 5 November 2020
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 128 (3) , 617
Re: Vitamin D and stress urinary incontinence in pregnancy: a cross‐sectional study
- 5 November 2020
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 128 (3) , 617
Open AccessRe: Vitamin D and stress urinary incontinence in pregnancy: a cross‐sectional study
- Open Access
- 8 December 2017
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 17 (1) , 414
Urothelial cells may indicate underlying bacteriuria in pregnancy at term: a comparative study
Urinary tract infection is common in pregnancy. Urine is sampled from by mid-stream collection (MSU). If epithelial cells are detected, contamination by vulvo-vagial skin and skin bacteria is assumed. Outside pregnancy, catheter specimen urine (CSU) is considered less susceptible to contamination. We compared MSU and CSU methods in term pregnancy to test these assumptions. Healthy pregnant women at term gestation (n = 32, median gestation 38 + 6 weeks, IQR 37 + 6–39 + 2) undergoing elective caesarean section provided a MSU and CSU for paired comparison that were each analysed for bacterial growth and bladder distress by fresh microscopy, sediment culture and immunofluorescent staining. Participants completed a detailed questionnaire on lower urinary tract symptoms. Epithelial cells found in urine were tested for urothelial origin by immunofluorescent staining of Uroplakin III (UP3), a urothelial cell surface glycoprotein. Urothelial cells with closely associated bacteria, or “clue cells”, were also counted. Wilcoxons signed rank test was used for paired analysis. Women reported multiple lower urinary tract symptoms (median 3, IQR 0–8). MSU had higher white blood cell counts (median 67 vs 46, z = 2.75, p = 0.005) and epithelial cell counts (median 41 vs 22, z = 2.57, p = 0.009) on fresh microscopy. The proportion of UP3+ cells was not different (0.920 vs 0.935, z = 0.08, p = 0.95), however MSU had a higher proportion of clue cells (0.978 vs 0.772, z = 3.17, p = 0.001). MSU had more bacterial growth on sediment culture compared to CSU specimens (median 8088 total cfu/ml vs 0, z = 4.86, p = 0.001). Despite this, routine laboratory cultures reported a negative screening culture for 40.6% of MSU specimens. Our findings have implications for the correct interpretation of MSU findings in term pregnancy. We observed that MSU samples had greater bacterial growth and variety when compared to CSU samples. The majority of epithelial cells in both MSU and CSU samples were urothelial in origin, implying no difference in contamination. MSU samples had a higher proportion of clue cells to UP3+ cells, indicating a greater sensitivity to bacterial invasion. Urinary epithelial cells should not be disregarded as contamination, instead alerting us to underlying bacterial activity.
- 8 December 2017
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 17 (1) , 414
Open AccessUrothelial cells may indicate underlying bacteriuria in pregnancy at term: a comparative study
Urinary tract infection is common in pregnancy. Urine is sampled from by mid-stream collection (MSU). If epithelial cells are detected, contamination by vulvo-vagial skin and skin bacteria is assumed. Outside pregnancy, catheter specimen urine (CSU) is considered less susceptible to contamination. We compared MSU and CSU methods in term pregnancy to test these assumptions. Healthy pregnant women at term gestation (n = 32, median gestation 38 + 6 weeks, IQR 37 + 6–39 + 2) undergoing elective caesarean section provided a MSU and CSU for paired comparison that were each analysed for bacterial growth and bladder distress by fresh microscopy, sediment culture and immunofluorescent staining. Participants completed a detailed questionnaire on lower urinary tract symptoms. Epithelial cells found in urine were tested for urothelial origin by immunofluorescent staining of Uroplakin III (UP3), a urothelial cell surface glycoprotein. Urothelial cells with closely associated bacteria, or “clue cells”, were also counted. Wilcoxons signed rank test was used for paired analysis. Women reported multiple lower urinary tract symptoms (median 3, IQR 0–8). MSU had higher white blood cell counts (median 67 vs 46, z = 2.75, p = 0.005) and epithelial cell counts (median 41 vs 22, z = 2.57, p = 0.009) on fresh microscopy. The proportion of UP3+ cells was not different (0.920 vs 0.935, z = 0.08, p = 0.95), however MSU had a higher proportion of clue cells (0.978 vs 0.772, z = 3.17, p = 0.001). MSU had more bacterial growth on sediment culture compared to CSU specimens (median 8088 total cfu/ml vs 0, z = 4.86, p = 0.001). Despite this, routine laboratory cultures reported a negative screening culture for 40.6% of MSU specimens. Our findings have implications for the correct interpretation of MSU findings in term pregnancy. We observed that MSU samples had greater bacterial growth and variety when compared to CSU samples. The majority of epithelial cells in both MSU and CSU samples were urothelial in origin, implying no difference in contamination. MSU samples had a higher proportion of clue cells to UP3+ cells, indicating a greater sensitivity to bacterial invasion. Urinary epithelial cells should not be disregarded as contamination, instead alerting us to underlying bacterial activity.